Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Germany's Discount Contracts Are Changing The Pharma Market Landscape

This article was originally published in The Pink Sheet Daily

Executive Summary

Regional firm wins an important tender, but at a discount that is so steep it attacks the process as creating "only losers."

Related Content

Germany’s New Non-Substitution Drug List No Big Bang For Pharma
Germany’s Grand Coalition Offers Pharma Little Certainty, Except For Continued Discounts
EU Pricing Pressures On Generics And Biosimilars Risk Killing Industry –EGA Execs
German Drug Report Could Mean More Pressure On Pharma Revenues
Generics Firms Culled In Germany As Discount Contracts Bite
Roche's Avastin Pay-For Performance Deal: The Future Of German Health Care?
Success Of German Cost-Control Law Raises Prospect Of Further Cuts For Pharma
Germany's Top Insurer Reveals Winners of Generic Discount Contracts; Losers Appeal
Spain Pushes Health Care Cuts To Help Avoid Financial Meltdown
German Rebate Contracts Under Threat From Legislation Promoting Patient Choice





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts